Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4244937
Max Phase: Preclinical
Molecular Formula: C27H32N2O2
Molecular Weight: 416.57
Molecule Type: Small molecule
Associated Items:
ID: ALA4244937
Max Phase: Preclinical
Molecular Formula: C27H32N2O2
Molecular Weight: 416.57
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=C(C=O)C[C@@H]12
Standard InChI: InChI=1S/C27H32N2O2/c1-26-11-9-19(31)14-18(26)7-8-20-21(26)10-12-27(2)22(20)13-17(15-30)25(27)29-16-28-23-5-3-4-6-24(23)29/h3-7,15-16,19-22,31H,8-14H2,1-2H3/t19-,20+,21-,22-,26-,27-/m0/s1
Standard InChI Key: BOVXPCGFUIXNNU-WNPREPMYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 416.57 | Molecular Weight (Monoisotopic): 416.2464 | AlogP: 5.38 | #Rotatable Bonds: 2 |
Polar Surface Area: 55.12 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 4.95 | CX LogP: 3.74 | CX LogD: 3.74 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.53 | Np Likeness Score: 1.10 |
1. Arellano Y, Bratoeff E, Heuze Y, Bravo M, Soriano J, Cabeza M.. (2018) Activity of steroid 4 and derivatives 4a-4f as inhibitors of the enzyme 5α-reductase 1., 26 (14): [PMID:30007568] [10.1016/j.bmc.2018.06.030] |
2. Huo H, Li G, Shi B, Li J.. (2022) Recent advances on synthesis and biological activities of C-17 aza-heterocycle derived steroids., 69 [PMID:35749841] [10.1016/j.bmc.2022.116882] |
Source(1):